Abstract Myelodysplastic syndromes (MDS) are a group of common hematological disorders with variable clinical presentations and prognoses. The incidence of this disease has a tendency to increase, both due to better awareness of general practitioners and availability of diagnostic tools, as well as the trend to community aging. On the other hand, the therapeutic options...
Pro zobrazení tohoto obsahu je třeba být přihlášen.